Kirkland Advises RLDatix on Merger of its Life Sciences Division with MediSpend to Create New Platform

Kirkland & Ellis represented RLDatix, a portfolio company of Five Arrows, TA Associates and Nordic Capital, in the merger of its RLDatix Life Sciences division with MediSpend, creating a new unified company at the forefront of life sciences innovation and compliance. The new company offers the most comprehensive suite of software, data and workflow tools to support the entire lifecycle for global compliance, transparency and sales enablement for the life sciences industry. The combined company currently serves over 300 pharmaceutical, biotech and medical device companies worldwide.